nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—Alzheimer's disease	0.434	1	CbGaD
Nebivolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.152	0.432	CbGbCtD
Nebivolol—CYP2D6—Donepezil—Alzheimer's disease	0.122	0.345	CbGbCtD
Nebivolol—CYP2D6—Galantamine—Alzheimer's disease	0.0785	0.223	CbGbCtD
Nebivolol—Claudication—Memantine—Alzheimer's disease	0.0135	0.0815	CcSEcCtD
Nebivolol—Intermittent claudication—Memantine—Alzheimer's disease	0.00729	0.0441	CcSEcCtD
Nebivolol—Peripheral ischaemia—Memantine—Alzheimer's disease	0.00571	0.0346	CcSEcCtD
Nebivolol—Peripheral ischaemia—Rivastigmine—Alzheimer's disease	0.00559	0.0338	CcSEcCtD
Nebivolol—Psoriasis—Donepezil—Alzheimer's disease	0.00365	0.0221	CcSEcCtD
Nebivolol—Atrioventricular block—Galantamine—Alzheimer's disease	0.00305	0.0185	CcSEcCtD
Nebivolol—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00249	0.277	CbGeAlD
Nebivolol—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00243	0.0147	CcSEcCtD
Nebivolol—Atrioventricular block—Donepezil—Alzheimer's disease	0.00237	0.0143	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.0022	0.0133	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00215	0.013	CcSEcCtD
Nebivolol—Atrioventricular block—Memantine—Alzheimer's disease	0.00215	0.013	CcSEcCtD
Nebivolol—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.0021	0.0127	CcSEcCtD
Nebivolol—Renal failure acute—Memantine—Alzheimer's disease	0.00164	0.00992	CcSEcCtD
Nebivolol—Renal failure acute—Rivastigmine—Alzheimer's disease	0.0016	0.0097	CcSEcCtD
Nebivolol—Bradycardia—Galantamine—Alzheimer's disease	0.00151	0.00916	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.0015	0.00908	CcSEcCtD
Nebivolol—Oedema peripheral—Galantamine—Alzheimer's disease	0.00146	0.00887	CcSEcCtD
Nebivolol—Cardiac disorder—Galantamine—Alzheimer's disease	0.00138	0.00835	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00136	0.00824	CcSEcCtD
Nebivolol—Mental disorder—Galantamine—Alzheimer's disease	0.0013	0.00789	CcSEcCtD
Nebivolol—Malnutrition—Galantamine—Alzheimer's disease	0.00129	0.00784	CcSEcCtD
Nebivolol—Bronchospasm—Memantine—Alzheimer's disease	0.00129	0.00778	CcSEcCtD
Nebivolol—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00127	0.00766	CcSEcCtD
Nebivolol—Myocardial infarction—Donepezil—Alzheimer's disease	0.00126	0.00762	CcSEcCtD
Nebivolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00126	0.00761	CcSEcCtD
Nebivolol—Erectile dysfunction—Memantine—Alzheimer's disease	0.0012	0.00729	CcSEcCtD
Nebivolol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00118	0.00713	CcSEcCtD
Nebivolol—Bradycardia—Donepezil—Alzheimer's disease	0.00117	0.0071	CcSEcCtD
Nebivolol—Vertigo—Galantamine—Alzheimer's disease	0.00116	0.00704	CcSEcCtD
Nebivolol—Syncope—Galantamine—Alzheimer's disease	0.00116	0.00703	CcSEcCtD
Nebivolol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00115	0.00695	CcSEcCtD
Nebivolol—Myocardial infarction—Memantine—Alzheimer's disease	0.00114	0.00692	CcSEcCtD
Nebivolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00114	0.00689	CcSEcCtD
Nebivolol—Oedema peripheral—Donepezil—Alzheimer's disease	0.00114	0.00687	CcSEcCtD
Nebivolol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00112	0.0068	CcSEcCtD
Nebivolol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00112	0.00677	CcSEcCtD
Nebivolol—Chest pain—Galantamine—Alzheimer's disease	0.0011	0.00667	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00109	0.00662	CcSEcCtD
Nebivolol—Bradycardia—Memantine—Alzheimer's disease	0.00107	0.00645	CcSEcCtD
Nebivolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00104	0.00631	CcSEcCtD
Nebivolol—Shock—Galantamine—Alzheimer's disease	0.00104	0.00629	CcSEcCtD
Nebivolol—Nervous system disorder—Galantamine—Alzheimer's disease	0.00104	0.00627	CcSEcCtD
Nebivolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00103	0.00626	CcSEcCtD
Nebivolol—Oedema peripheral—Memantine—Alzheimer's disease	0.00103	0.00624	CcSEcCtD
Nebivolol—Skin disorder—Galantamine—Alzheimer's disease	0.00103	0.00621	CcSEcCtD
Nebivolol—Mental disorder—Donepezil—Alzheimer's disease	0.00101	0.00611	CcSEcCtD
Nebivolol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00101	0.0061	CcSEcCtD
Nebivolol—Malnutrition—Donepezil—Alzheimer's disease	0.001	0.00607	CcSEcCtD
Nebivolol—Cardiac disorder—Memantine—Alzheimer's disease	0.000971	0.00588	CcSEcCtD
Nebivolol—Insomnia—Galantamine—Alzheimer's disease	0.000955	0.00578	CcSEcCtD
Nebivolol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00095	0.00575	CcSEcCtD
Nebivolol—Paraesthesia—Galantamine—Alzheimer's disease	0.000948	0.00574	CcSEcCtD
Nebivolol—Somnolence—Galantamine—Alzheimer's disease	0.000939	0.00568	CcSEcCtD
Nebivolol—Mental disorder—Memantine—Alzheimer's disease	0.000917	0.00555	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000912	0.00552	CcSEcCtD
Nebivolol—Malnutrition—Memantine—Alzheimer's disease	0.000911	0.00551	CcSEcCtD
Nebivolol—Fatigue—Galantamine—Alzheimer's disease	0.000911	0.00551	CcSEcCtD
Nebivolol—Vertigo—Donepezil—Alzheimer's disease	0.000901	0.00546	CcSEcCtD
Nebivolol—Syncope—Donepezil—Alzheimer's disease	0.000899	0.00545	CcSEcCtD
Nebivolol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000897	0.00543	CcSEcCtD
Nebivolol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000891	0.00539	CcSEcCtD
Nebivolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000882	0.00534	CcSEcCtD
Nebivolol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000864	0.00523	CcSEcCtD
Nebivolol—Chest pain—Donepezil—Alzheimer's disease	0.000854	0.00517	CcSEcCtD
Nebivolol—Abdominal pain—Galantamine—Alzheimer's disease	0.000835	0.00506	CcSEcCtD
Nebivolol—Vertigo—Memantine—Alzheimer's disease	0.000818	0.00495	CcSEcCtD
Nebivolol—Syncope—Memantine—Alzheimer's disease	0.000817	0.00494	CcSEcCtD
Nebivolol—Shock—Donepezil—Alzheimer's disease	0.000805	0.00488	CcSEcCtD
Nebivolol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000803	0.00486	CcSEcCtD
Nebivolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000802	0.00485	CcSEcCtD
Nebivolol—Vertigo—Rivastigmine—Alzheimer's disease	0.0008	0.00485	CcSEcCtD
Nebivolol—Loss of consciousness—Memantine—Alzheimer's disease	0.0008	0.00485	CcSEcCtD
Nebivolol—Syncope—Rivastigmine—Alzheimer's disease	0.000799	0.00484	CcSEcCtD
Nebivolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000783	0.00474	CcSEcCtD
Nebivolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000778	0.00471	CcSEcCtD
Nebivolol—Chest pain—Memantine—Alzheimer's disease	0.000775	0.00469	CcSEcCtD
Nebivolol—ADRB1—forebrain—Alzheimer's disease	0.000759	0.0843	CbGeAlD
Nebivolol—Chest pain—Rivastigmine—Alzheimer's disease	0.000759	0.00459	CcSEcCtD
Nebivolol—Asthenia—Galantamine—Alzheimer's disease	0.000758	0.00459	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000753	0.00456	CcSEcCtD
Nebivolol—Insomnia—Donepezil—Alzheimer's disease	0.00074	0.00448	CcSEcCtD
Nebivolol—Paraesthesia—Donepezil—Alzheimer's disease	0.000735	0.00445	CcSEcCtD
Nebivolol—Shock—Memantine—Alzheimer's disease	0.000731	0.00443	CcSEcCtD
Nebivolol—Dyspnoea—Donepezil—Alzheimer's disease	0.00073	0.00442	CcSEcCtD
Nebivolol—Nervous system disorder—Memantine—Alzheimer's disease	0.000729	0.00441	CcSEcCtD
Nebivolol—Somnolence—Donepezil—Alzheimer's disease	0.000728	0.00441	CcSEcCtD
Nebivolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000728	0.00441	CcSEcCtD
Nebivolol—Diarrhoea—Galantamine—Alzheimer's disease	0.000723	0.00438	CcSEcCtD
Nebivolol—Skin disorder—Memantine—Alzheimer's disease	0.000722	0.00437	CcSEcCtD
Nebivolol—Shock—Rivastigmine—Alzheimer's disease	0.000715	0.00433	CcSEcCtD
Nebivolol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000713	0.00432	CcSEcCtD
Nebivolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000712	0.00431	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000707	0.00428	CcSEcCtD
Nebivolol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000706	0.00428	CcSEcCtD
Nebivolol—Fatigue—Donepezil—Alzheimer's disease	0.000706	0.00427	CcSEcCtD
Nebivolol—Dizziness—Galantamine—Alzheimer's disease	0.000698	0.00423	CcSEcCtD
Nebivolol—ADRB1—telencephalon—Alzheimer's disease	0.000698	0.0775	CbGeAlD
Nebivolol—Insomnia—Memantine—Alzheimer's disease	0.000672	0.00407	CcSEcCtD
Nebivolol—Vomiting—Galantamine—Alzheimer's disease	0.000672	0.00407	CcSEcCtD
Nebivolol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000669	0.00405	CcSEcCtD
Nebivolol—Paraesthesia—Memantine—Alzheimer's disease	0.000667	0.00404	CcSEcCtD
Nebivolol—Rash—Galantamine—Alzheimer's disease	0.000666	0.00403	CcSEcCtD
Nebivolol—Dermatitis—Galantamine—Alzheimer's disease	0.000665	0.00403	CcSEcCtD
Nebivolol—Dyspnoea—Memantine—Alzheimer's disease	0.000663	0.00401	CcSEcCtD
Nebivolol—Headache—Galantamine—Alzheimer's disease	0.000662	0.00401	CcSEcCtD
Nebivolol—Somnolence—Memantine—Alzheimer's disease	0.000661	0.004	CcSEcCtD
Nebivolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000658	0.00398	CcSEcCtD
Nebivolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000653	0.00395	CcSEcCtD
Nebivolol—HTR1A—forebrain—Alzheimer's disease	0.000651	0.0723	CbGeAlD
Nebivolol—Urticaria—Donepezil—Alzheimer's disease	0.00065	0.00394	CcSEcCtD
Nebivolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000648	0.00392	CcSEcCtD
Nebivolol—Abdominal pain—Donepezil—Alzheimer's disease	0.000647	0.00392	CcSEcCtD
Nebivolol—Somnolence—Rivastigmine—Alzheimer's disease	0.000646	0.00391	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000642	0.00388	CcSEcCtD
Nebivolol—Fatigue—Memantine—Alzheimer's disease	0.000641	0.00388	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000628	0.0038	CcSEcCtD
Nebivolol—Nausea—Galantamine—Alzheimer's disease	0.000627	0.0038	CcSEcCtD
Nebivolol—Fatigue—Rivastigmine—Alzheimer's disease	0.000627	0.0038	CcSEcCtD
Nebivolol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000608	0.00368	CcSEcCtD
Nebivolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000603	0.00365	CcSEcCtD
Nebivolol—HTR1A—telencephalon—Alzheimer's disease	0.000599	0.0665	CbGeAlD
Nebivolol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000595	0.0036	CcSEcCtD
Nebivolol—Urticaria—Memantine—Alzheimer's disease	0.00059	0.00357	CcSEcCtD
Nebivolol—Abdominal pain—Memantine—Alzheimer's disease	0.000588	0.00356	CcSEcCtD
Nebivolol—Asthenia—Donepezil—Alzheimer's disease	0.000587	0.00356	CcSEcCtD
Nebivolol—Pruritus—Donepezil—Alzheimer's disease	0.000579	0.00351	CcSEcCtD
Nebivolol—Urticaria—Rivastigmine—Alzheimer's disease	0.000578	0.0035	CcSEcCtD
Nebivolol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000575	0.00348	CcSEcCtD
Nebivolol—Diarrhoea—Donepezil—Alzheimer's disease	0.00056	0.00339	CcSEcCtD
Nebivolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000548	0.00332	CcSEcCtD
Nebivolol—Dizziness—Donepezil—Alzheimer's disease	0.000541	0.00328	CcSEcCtD
Nebivolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000536	0.00324	CcSEcCtD
Nebivolol—Asthenia—Memantine—Alzheimer's disease	0.000533	0.00323	CcSEcCtD
Nebivolol—Pruritus—Memantine—Alzheimer's disease	0.000526	0.00318	CcSEcCtD
Nebivolol—Asthenia—Rivastigmine—Alzheimer's disease	0.000522	0.00316	CcSEcCtD
Nebivolol—Vomiting—Donepezil—Alzheimer's disease	0.00052	0.00315	CcSEcCtD
Nebivolol—Rash—Donepezil—Alzheimer's disease	0.000516	0.00312	CcSEcCtD
Nebivolol—Dermatitis—Donepezil—Alzheimer's disease	0.000516	0.00312	CcSEcCtD
Nebivolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000514	0.00311	CcSEcCtD
Nebivolol—Headache—Donepezil—Alzheimer's disease	0.000513	0.0031	CcSEcCtD
Nebivolol—Diarrhoea—Memantine—Alzheimer's disease	0.000509	0.00308	CcSEcCtD
Nebivolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000498	0.00301	CcSEcCtD
Nebivolol—Dizziness—Memantine—Alzheimer's disease	0.000492	0.00298	CcSEcCtD
Nebivolol—Nausea—Donepezil—Alzheimer's disease	0.000486	0.00294	CcSEcCtD
Nebivolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000481	0.00291	CcSEcCtD
Nebivolol—Vomiting—Memantine—Alzheimer's disease	0.000473	0.00286	CcSEcCtD
Nebivolol—Rash—Memantine—Alzheimer's disease	0.000469	0.00284	CcSEcCtD
Nebivolol—Dermatitis—Memantine—Alzheimer's disease	0.000468	0.00283	CcSEcCtD
Nebivolol—Headache—Memantine—Alzheimer's disease	0.000466	0.00282	CcSEcCtD
Nebivolol—Vomiting—Rivastigmine—Alzheimer's disease	0.000462	0.0028	CcSEcCtD
Nebivolol—Rash—Rivastigmine—Alzheimer's disease	0.000458	0.00278	CcSEcCtD
Nebivolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000458	0.00277	CcSEcCtD
Nebivolol—Headache—Rivastigmine—Alzheimer's disease	0.000456	0.00276	CcSEcCtD
Nebivolol—Nausea—Memantine—Alzheimer's disease	0.000441	0.00267	CcSEcCtD
Nebivolol—Nausea—Rivastigmine—Alzheimer's disease	0.000432	0.00261	CcSEcCtD
Nebivolol—ADRB1—nervous system—Alzheimer's disease	0.000412	0.0458	CbGeAlD
Nebivolol—ADRB1—central nervous system—Alzheimer's disease	0.000397	0.0441	CbGeAlD
Nebivolol—CYP2D6—forebrain—Alzheimer's disease	0.000353	0.0393	CbGeAlD
Nebivolol—HTR1A—nervous system—Alzheimer's disease	0.000353	0.0393	CbGeAlD
Nebivolol—HTR1A—central nervous system—Alzheimer's disease	0.00034	0.0378	CbGeAlD
Nebivolol—HTR1A—cerebellum—Alzheimer's disease	0.000333	0.0369	CbGeAlD
Nebivolol—CYP2D6—telencephalon—Alzheimer's disease	0.000325	0.0361	CbGeAlD
Nebivolol—ADRB1—brain—Alzheimer's disease	0.000315	0.035	CbGeAlD
Nebivolol—HTR1A—brain—Alzheimer's disease	0.00027	0.03	CbGeAlD
Nebivolol—CYP2D6—nervous system—Alzheimer's disease	0.000192	0.0213	CbGeAlD
Nebivolol—CYP2D6—central nervous system—Alzheimer's disease	0.000185	0.0205	CbGeAlD
Nebivolol—CYP2D6—cerebellum—Alzheimer's disease	0.000181	0.0201	CbGeAlD
Nebivolol—CYP2D6—brain—Alzheimer's disease	0.000147	0.0163	CbGeAlD
Nebivolol—CYP2D6—Metabolism—CA4—Alzheimer's disease	3.32e-05	0.00085	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.31e-05	0.000849	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	3.3e-05	0.000844	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.29e-05	0.000842	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	3.25e-05	0.000834	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	3.25e-05	0.000832	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	3.25e-05	0.000832	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.24e-05	0.00083	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	3.22e-05	0.000826	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.22e-05	0.000824	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	3.18e-05	0.000814	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	3.18e-05	0.000814	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	3.16e-05	0.00081	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.14e-05	0.000805	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	3.12e-05	0.000799	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	3.12e-05	0.000799	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	3.11e-05	0.000795	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	3.11e-05	0.000795	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	3.09e-05	0.000793	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	3.06e-05	0.000784	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	3.05e-05	0.000781	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.04e-05	0.000778	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	3.03e-05	0.000775	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	3.02e-05	0.000773	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	2.99e-05	0.000767	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.99e-05	0.000765	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	2.98e-05	0.000764	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.96e-05	0.000758	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	2.95e-05	0.000756	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	2.94e-05	0.000752	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	2.93e-05	0.00075	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.92e-05	0.000748	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	2.89e-05	0.000739	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	2.87e-05	0.000736	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	2.86e-05	0.000734	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	2.86e-05	0.000731	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.82e-05	0.000723	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	2.81e-05	0.00072	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	2.8e-05	0.000718	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	2.8e-05	0.000717	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	2.8e-05	0.000717	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	2.74e-05	0.000702	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	2.74e-05	0.000701	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	2.74e-05	0.000701	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.71e-05	0.000693	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	2.68e-05	0.000686	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	2.68e-05	0.000686	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.6e-05	0.000667	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	2.52e-05	0.000644	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	2.47e-05	0.000632	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.43e-05	0.000623	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	2.41e-05	0.000618	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	2.39e-05	0.000612	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.38e-05	0.000609	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	2.36e-05	0.000604	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	2.34e-05	0.000598	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.33e-05	0.000596	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.3e-05	0.00059	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	2.28e-05	0.000585	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.25e-05	0.000578	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	2.25e-05	0.000577	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.21e-05	0.000566	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.21e-05	0.000565	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	2.2e-05	0.000564	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	2.2e-05	0.000563	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	2.18e-05	0.00056	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.16e-05	0.000553	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.16e-05	0.000552	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	2.15e-05	0.000551	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	2.14e-05	0.000547	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	2.12e-05	0.000543	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.11e-05	0.000541	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	2.1e-05	0.000539	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	2.09e-05	0.000536	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	2.09e-05	0.000535	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	2.07e-05	0.000531	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.05e-05	0.000524	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	2.05e-05	0.000524	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	2.03e-05	0.00052	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	2.01e-05	0.000515	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	2e-05	0.000513	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	2e-05	0.000513	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	2e-05	0.000512	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.98e-05	0.000506	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.97e-05	0.000505	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.97e-05	0.000504	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.96e-05	0.000502	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.96e-05	0.000501	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.93e-05	0.000495	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.93e-05	0.000494	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	1.92e-05	0.000493	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.92e-05	0.000491	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.92e-05	0.000491	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.92e-05	0.000491	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.91e-05	0.00049	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.91e-05	0.000489	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.9e-05	0.000487	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	1.89e-05	0.000484	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	1.89e-05	0.000483	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.88e-05	0.000481	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.88e-05	0.000481	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.88e-05	0.000481	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.87e-05	0.000479	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.87e-05	0.000479	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.86e-05	0.000476	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SST—Alzheimer's disease	1.83e-05	0.00047	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	1.83e-05	0.00047	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	1.83e-05	0.00047	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.83e-05	0.000468	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	1.83e-05	0.000468	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	1.82e-05	0.000466	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.79e-05	0.00046	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APP—Alzheimer's disease	1.79e-05	0.000458	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.76e-05	0.000452	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.76e-05	0.00045	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.72e-05	0.000442	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	1.72e-05	0.00044	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.69e-05	0.000432	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.65e-05	0.000421	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.63e-05	0.000419	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.62e-05	0.000415	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.62e-05	0.000415	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.61e-05	0.000412	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.61e-05	0.000412	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.6e-05	0.00041	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.6e-05	0.00041	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	1.57e-05	0.000403	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.57e-05	0.000403	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.56e-05	0.000401	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.56e-05	0.000401	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.55e-05	0.000398	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.54e-05	0.000394	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.53e-05	0.000392	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.52e-05	0.000389	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.5e-05	0.000383	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.49e-05	0.000381	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	1.45e-05	0.000372	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.45e-05	0.000371	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.44e-05	0.00037	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.42e-05	0.000363	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.4e-05	0.000358	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	1.38e-05	0.000355	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.37e-05	0.000351	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	1.34e-05	0.000344	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.34e-05	0.000343	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	1.33e-05	0.000341	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.31e-05	0.000336	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	1.3e-05	0.000334	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.3e-05	0.000333	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	1.28e-05	0.000329	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	1.28e-05	0.000327	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.27e-05	0.000326	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	1.27e-05	0.000325	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.26e-05	0.000322	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.25e-05	0.00032	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	1.24e-05	0.000318	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.24e-05	0.000318	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	1.24e-05	0.000317	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	1.22e-05	0.000311	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	1.18e-05	0.000303	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	0.000303	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.18e-05	0.000302	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.18e-05	0.000302	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.16e-05	0.000296	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	1.13e-05	0.000289	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	1.12e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	1.12e-05	0.000288	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	1.11e-05	0.000285	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	1.1e-05	0.000283	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	1.1e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	1.1e-05	0.000282	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.09e-05	0.00028	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	1.09e-05	0.000279	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000276	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	1.08e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	1.08e-05	0.000275	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	1.07e-05	0.000275	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	1.07e-05	0.000273	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	1.06e-05	0.000272	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	1.05e-05	0.000269	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.04e-05	0.000266	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	1.04e-05	0.000266	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.03e-05	0.000265	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	1.03e-05	0.000263	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.01e-05	0.00026	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	0.00026	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	1e-05	0.000257	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.92e-06	0.000254	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	9.74e-06	0.000249	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	9.66e-06	0.000247	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	9.6e-06	0.000246	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	9.52e-06	0.000244	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	9.45e-06	0.000242	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	9.45e-06	0.000242	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	9.4e-06	0.000241	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	9.31e-06	0.000239	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	9.29e-06	0.000238	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	9.24e-06	0.000237	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	9.24e-06	0.000237	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INS—Alzheimer's disease	9.19e-06	0.000235	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	9.09e-06	0.000233	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	9.04e-06	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	8.89e-06	0.000228	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	8.63e-06	0.000221	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	8.59e-06	0.00022	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	8.42e-06	0.000216	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	8.24e-06	0.000211	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	8.06e-06	0.000206	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	7.86e-06	0.000201	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	7.22e-06	0.000185	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	7.15e-06	0.000183	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	7.1e-06	0.000182	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	7.07e-06	0.000181	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	7.06e-06	0.000181	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	6.99e-06	0.000179	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	6.95e-06	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.9e-06	0.000177	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	6.84e-06	0.000175	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	6.8e-06	0.000174	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	6.61e-06	0.000169	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	6.59e-06	0.000169	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	6.57e-06	0.000168	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	6.55e-06	0.000168	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	6.53e-06	0.000167	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	6.43e-06	0.000165	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	6.41e-06	0.000164	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	6.29e-06	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	6.27e-06	0.000161	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	6.07e-06	0.000155	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	5.94e-06	0.000152	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	5.8e-06	0.000149	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	5.74e-06	0.000147	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INS—Alzheimer's disease	5.63e-06	0.000144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	5.57e-06	0.000143	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	5.45e-06	0.00014	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	5.33e-06	0.000136	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.93e-06	0.000126	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	4.58e-06	0.000117	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	4.51e-06	0.000116	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	4.48e-06	0.000115	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	4.39e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	4.2e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	4.11e-06	0.000105	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	4.01e-06	0.000103	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	3.87e-06	9.92e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	3.79e-06	9.7e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	3.7e-06	9.49e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.27e-06	5.81e-05	CbGpPWpGaD
